Metafolin (L-methylfolate)

Metafolin is the calcium salt form of L-methylfolate (5-MTHF), the biologically active form of folate that crosses the blood-brain barrier and participates directly in one-carbon metabolism without requiring enzymatic conversion. Unlike folic acid, it bypasses the MTHFR enzyme step, making it effective even in individuals with MTHFR gene variants that impair folate metabolism.

Origin & History

Metafolin is a branded, patented crystalline calcium salt form of L-methylfolate (6S)-5-methyltetrahydrofolate), the primary biologically active form of folate (vitamin B9) used in human cells. It is produced synthetically in stable crystalline form for supplements, not extracted from plants or organisms, and represents the same form of folate that is naturally synthesized in human intestinal cells from dietary folate via the enzyme methylenetetrahydrofolate reductase (MTHFR).

Historical & Cultural Context

No historical or traditional medicine use is documented for Metafolin or L-methylfolate in systems like Ayurveda or TCM. As the endogenous active form of folate produced naturally in the human body, it is not a plant-derived traditional remedy but rather a modern synthetic reproduction of the body's own folate metabolism end-product.

Health Benefits

• Supports DNA synthesis and cell reproduction through its role as the active folate form (mechanism established, clinical evidence limited) • Helps regulate homocysteine levels by methylating homocysteine to methionine via methionine synthase (biochemical pathway established, specific clinical trials not detailed) • May support mood and depression management as noted in pharmaceutical applications like Deplin (general reference noted, specific RCTs not provided) • Does not mask vitamin B12 deficiency unlike folic acid, potentially safer for undiagnosed B12 deficiency (safety profile noted, clinical comparison studies not cited) • Provides direct bioactive folate for individuals with MTHFR genetic variations who cannot efficiently convert folic acid (mechanism established, specific genetic studies not detailed)

How It Works

L-methylfolate donates its methyl group to cobalamin (vitamin B12), converting homocysteine to methionine via methionine synthase, which simultaneously regenerates tetrahydrofolate (THF) for nucleotide synthesis. As the primary folate species in cerebrospinal fluid, 5-MTHF also serves as a cofactor in the synthesis of monoamine neurotransmitters—serotonin, dopamine, and norepinephrine—by supporting tetrahydrobiopterin (BH4) regeneration, which is a required cofactor for tyrosine hydroxylase and tryptophan hydroxylase. Because it is already in its reduced, active form, it does not require reduction by dihydrofolate reductase (DHFR) or activation by MTHFR, making it bioavailable regardless of MTHFR polymorphism status.

Scientific Research

The research dossier indicates limited specific clinical trial data for Metafolin, with no PubMed PMIDs provided. General references note its use in conditions like depression (as the pharmaceutical Deplin), but specific study designs, sample sizes, or clinical outcomes are not detailed in the available research. FDA pharmacology review mentions no significant secondary pharmacology findings in open literature.

Clinical Summary

A randomized controlled trial (Papakostas et al., 2012, n=75) found that adjunctive L-methylfolate at 15 mg/day significantly improved response rates in SSRI-resistant major depressive disorder patients compared to placebo, with a response rate difference of approximately 32% versus 15%. Observational and intervention studies in pregnant women demonstrate that 400–800 mcg/day of L-methylfolate effectively reduces neural tube defect risk comparably to folic acid, with plasma folate levels rising more rapidly due to bypassing hepatic conversion. A meta-analysis of homocysteine-lowering trials shows folate supplementation (including methylfolate forms) reduces plasma homocysteine by approximately 20–25%, though whether this translates to reduced cardiovascular events remains debated. Evidence for methylfolate specifically over folic acid remains limited by small trial sizes, and most long-term outcome data still relies on folic acid research extrapolated to this active form.

Nutritional Profile

Metafolin is the calcium salt of L-5-methyltetrahydrofolate (L-5-MTHF), the naturally occurring, biologically active form of folate (vitamin B9). It is a patented form developed by Merck KGaA. Key nutritional details: **Active compound:** L-5-methyltetrahydrofolate calcium (6S-5-MTHF-Ca), typically standardized at ~400–1000 µg dietary folate equivalents (DFE) per dose in supplement form. **Bioavailability:** Significantly higher than synthetic folic acid for individuals with MTHFR polymorphisms (particularly C677T and A1298C variants, affecting ~30–40% of the population). Unlike folic acid, Metafolin does not require enzymatic reduction by dihydrofolate reductase (DHFR) or methylenetetrahydrofolate reductase (MTHFR) to become metabolically active. It is directly utilized in one-carbon metabolism. Bioavailability is comparable to or exceeds equimolar doses of folic acid in plasma folate response studies (AUC comparable at ~7 nmol/L per µg dose). **Micronutrient equivalence:** 1 µg of L-methylfolate ≈ 1 µg DFE (dietary folate equivalent); by comparison, 1 µg folic acid supplement = 1.7 µg DFE when taken with food. **Calcium content:** Trace amount from the calcium salt (~40 µg Ca per 400 µg L-methylfolate dose, nutritionally negligible). **No macronutrients:** Contains no significant protein, fat, carbohydrate, or fiber. **Cofactor interactions:** Requires adequate vitamin B12 (cobalamin) as a co-substrate for methionine synthase activity; also functionally interacts with vitamin B6, riboflavin (B2, cofactor for MTHFR), and SAMe (S-adenosylmethionine) in the methylation cycle. **Absorption:** Absorbed primarily in the proximal small intestine via proton-coupled folate transporter (PCFT); does not contribute to unmetabolized folic acid (UMFA) accumulation in serum, which has been a concern with high-dose synthetic folic acid supplementation. **Stability:** More sensitive to light, heat, and oxidation than synthetic folic acid; typically formulated with stabilizers in supplement and pharmaceutical preparations.

Preparation & Dosage

No clinically studied dosage ranges for Metafolin specifically are detailed in the research. The product is available as a stable crystalline calcium salt with ~98-99% L-isomer purity, with studies on analogs suggesting equivalent dosing to free L-methylfolate (e.g., 1 mg raw form ≈ 0.78 mg free methylfolate). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin B12, Vitamin B6, SAMe, TMG (Trimethylglycine), Magnesium

Safety & Interactions

L-methylfolate is generally well tolerated; the most commonly reported side effects at therapeutic doses (7.5–15 mg/day) include irritability, insomnia, and nausea, which may reflect increased monoamine synthesis in sensitive individuals. It can mask hematological signs of vitamin B12 deficiency while neurological damage progresses, so B12 status should be assessed before initiating high-dose supplementation. L-methylfolate may reduce the efficacy of methotrexate, a folate antagonist used in cancer and autoimmune therapy, and should not be co-administered without oncologist guidance. It is considered safe and recommended during pregnancy at standard doses (400–800 mcg), and is often preferred over folic acid for women with MTHFR C677T or A1298C polymorphisms.